| Medical and Health Sciences | Lifetime | 309 | US 170 | 99.99 |
| Pulmonary and Respiratory Medicine | Lifetime | 47 | US 24 | 99.94 |
| Gastroenterology | Lifetime | 15 | US 7 | 99.82 |
| Rheumatology | Lifetime | 101 | US 46 | 99.56 |
| Oncology | Lifetime | 271 | US 154 | 99.56 |
| Surgery | Lifetime | 661 | US 361 | 99.38 |
| Pathology and Forensic Medicine | Lifetime | 212 | US 111 | 99.22 |
| Clinical Neurology | Lifetime | 289 | US 131 | 98.87 |
| Cell Biology | Lifetime | 343 | US 199 | 98.36 |
| Dermatology | Lifetime | 507 | US 209 | 96.08 |
| Oral Surgery | Lifetime | 716 | US 172 | 92.29 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 966 | US 354 | 86.60 |
| Gastrointestinal Tumor Research and Treatment | Lifetime | 2 | US 1 | 99.96 |
| Gastrointestinal disorders and treatments | Lifetime | 5 | US 3 | 99.93 |
| Sarcoma Diagnosis and Treatment | Lifetime | 6 | US 5 | 99.95 |
| Oral and Maxillofacial Pathology | Lifetime | 10 | US 4 | 99.83 |
| Soft tissue tumor case studies | Lifetime | 2 | US 2 | 99.94 |
| Tumors and Oncological Cases | Lifetime | 5 | US 5 | 99.83 |
| Neurofibromatosis and Schwannoma Cases | Lifetime | 5 | US 5 | 99.90 |
| Vascular Tumors and Angiosarcomas | Lifetime | 6 | US 5 | 99.82 |
| Cardiac tumors and thrombi | Lifetime | 17 | US 9 | 99.76 |
| Soft tissue tumors and treatment | Lifetime | 2 | US 2 | 99.82 |
| Metastasis and carcinoma case studies | Lifetime | 28 | US 5 | 99.49 |
| Skin and Cellular Biology Research | Lifetime | 20 | US 13 | 99.49 |
| Bone Tumor Diagnosis and Treatments | Lifetime | 43 | US 23 | 99.52 |
| Cancer and Skin Lesions | Lifetime | 57 | US 31 | 99.27 |
| Vascular Malformations and Hemangiomas | Lifetime | 32 | US 21 | 98.91 |
| Urologic and reproductive health conditions | Lifetime | 79 | US 46 | 99.41 |
| Histiocytic Disorders and Treatments | Lifetime | 36 | US 22 | 98.81 |
| Neuroblastoma Research and Treatments | Lifetime | 192 | US 107 | 98.70 |
| Salivary Gland Tumors Diagnosis and Treatment | Lifetime | 225 | US 117 | 98.39 |
| Gastric Cancer Management and Outcomes | Lifetime | 721 | US 229 | 98.54 |
| Neuroendocrine Tumor Research Advances | Lifetime | 567 | US 235 | 98.12 |
| Adrenal and Paraganglionic Tumors | Lifetime | 218 | US 84 | 97.99 |
| Cell Adhesion Molecules Research | Lifetime | 778 | US 381 | 97.77 |
| Occupational and environmental lung diseases | Lifetime | 338 | US 141 | 96.43 |
| Wnt/β-catenin signaling in development and cancer | Lifetime | 377 | US 165 | 95.87 |
| Cutaneous lymphoproliferative disorders research | Lifetime | 413 | US 169 | 96.26 |
| Toxin Mechanisms and Immunotoxins | Lifetime | 777 | US 372 | 94.46 |
| Ear and Head Tumors | Lifetime | 602 | US 315 | 94.65 |
| Musculoskeletal synovial abnormalities and treatments | Lifetime | 662 | US 279 | 92.87 |
| Chromatin Remodeling and Cancer | Lifetime | 995 | US 440 | 82.30 |
| Sarcoma Diagnosis and Treatment | 2021-2025 | 427 | US 161 | 92.83 |
| Tumors and Oncological Cases | 2021-2025 | 211 | US 75 | 82.75 |
| Soft tissue tumor case studies | 2021-2025 | 412 | US 145 | 64.97 |
